Gregory Weaver, Former EVP, CFO, & Director, Director at Atossa Therapeutics, holds 55.00 shares in Atossa Therapeutics (Ticker: ATOS), holds 4.67K shares in ATAI Life Sciences (Ticker: ATAI), holds 10.43K shares in Eloxx Pharmaceuticals (Ticker: ELOX). Most recently, Gregory Weaver Sold ― shares of Atossa Therapeutics on Nov 17, 2023 for an estimated value of 32.50K.